SCHEMBL6173086

SCHEMBL6173086

Cc1ccc(CCC(CO)n2cnc(C(N)=O)c2)cc1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADA P00813 19/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27547750 0.89 ADA (0.80) ADA
Fr-221647 SCHEMBL7659103 0.88 ADA (1.00) ADA
SCHEMBL7670504 0.86 ADA (0.75) ADA
SCHEMBL6170281 0.84 ADA (0.56) ADA
SCHEMBL7457279 0.81 ADA (0.78) ADA
SCHEMBL6173090 0.81 ADA (0.51) ADA
SCHEMBL7657591 0.80 ADA (0.66) ADA
SCHEMBL7664339 0.80 ADA (0.69) ADA
SCHEMBL7668671 0.80 ADA (0.77) ADA
SCHEMBL7664981 0.80 ADA (0.77) ADA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098885-B9 IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2005-05-18 EP disclosed
EP-1098885-B1 IMIDAZOLE COMPOUNDS AND THEIR USE AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2004-11-17 EP disclosed
US-6359145-B1 ADENOSINE DEAMINASE INHIBITOR; ANTIINFLAMMATORY AGENTS; IMMUNOSUPPRESSANT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed